In a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of lung cancer.
Drs. Avianne Bunnell, Quiana Kern and Kiandra Scott are pursuing surgical specialties at MUSC.
Nancy DeMore, M.D. teamed up with Clemson engineering students to work on a device that will improve patient experience and lower costs.